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1  | INTRODUC TION
Osteoarthritis (OA) has an estimated prevalence of 10%-30% world-
wide1,2; however, most interventions treat the symptoms of the 
disease, rather than the cause. Ankle OA creates a particular prob-
lem, as the disease is estimated to be post-traumatic in anywhere 
between 18% and 75% of cases.3-5 This results in a much earlier age 
of onset, with the average symptomatic ankle OA patient being aged 
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Abstract
A large proportion of ankle osteoarthritis (OA) has an early onset and is post-trau-
matic. Surgical interventions have low patient satisfaction and relatively poor clinical 
outcome, whereas joint-preserving treatments, which rely on endogenous multipo-
tential stromal cells (MSCs), result in suboptimal repair. This study investigates MSC 
presence and potency in OA-affected talocrural osteochondral tissue. Bone volume 
fraction (BV/TV) changes for the loading region trabecular volume and subchondral 
bone plate (SBP) thickness in OA compared with healthy tissue were investigated 
using microcomputed tomography. CD271-positive MSC topography was related to 
bone and cartilage damage in OA tissue, and in vitro MSC potency was compared 
with control healthy iliac crest (IC) MSCs. A 1.3- to 2.5-fold SBP thickening was found 
in both OA talus and tibia, whereas BV/TV changes were depth-dependent. MSCs 
were abundant in OA talus and tibia, with similar colony characteristics. Tibial and 
talar MSCs were tripotential, but talar MSCs had 10-fold lower adipogenesis and 
twofold higher chondrogenesis than IC MSCs (P = .01 for both). Cartilage damage in 
both OA tibia and talus correlated with SBP thickening and CD271+ MSCs was 1.4- 
to twofold more concentrated near the SBP. This work shows multipotential MSCs 
are present in OA talocrural subchondral bone, with their topography suggesting 
ongoing involvement in SBP thickening. Potentially, biomechanical stimulation could 
augment the chondrogenic differentiation of MSCs for joint-preserving treatments.
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only 51.5 years, compared with 63 in the hip.5-7 The structure of 
the ankle is different from the knee or hip, with far more congru-
ency, thought to be related to the entire joint being used to offset 
load, rather than support soft tissue.8 There is a dire need to under-
stand how this affects OA, and how this relates to the cellular level, 
in order to enhance the efficacy of regenerative repair treatments 
through evidence-based design.
The current treatment with the best clinical outcome is the 
fusion of the ankle, which is typically employed at age 68 years, 
approximately 16 years after onset.5 This waiting period creates 
a need for earlier, joint-preserving interventions. Total ankle re-
placement is another surgical treatment option, having higher 
patient satisfaction; however, there is a shorter life-time of the 
treatment.9 Early-stage interventions are mostly analgesics, or at-
tempts to induce natural regeneration using joint-resident cells.10 
Typical early-stage interventions include the removal of damaged 
cartilage, usually followed with further regenerative treatment. 
One example is microfracture, which involves drilling into the 
bone until the release of fat and blood, simultaneously releasing 
bone marrow resident reparative cells to create de novo cartilage. 
Other options include autologous osteochondral transplant (AOT) 
or joint distraction.11,12 Each of these treatments relies on endog-
enous cells to remodel the nearby area.13 These treatments show 
high success rates and patient satisfaction up until 2 years; how-
ever, the formation of fibrocartilage eventually leads to treatment 
failure.14
Local multipotential stromal cells (MSCs) are implicated in these 
treatments as the major regenerative cell within the joint; however, 
their behaviour is poorly understood within the ankle compared 
with other joints like hip and knee.13 As MSCs are unlikely to be 
transported by blood15,16; the subchondral bone, synovial fluid or 
synovium are considered to be the main MSC tissue sources within 
joints.17 In ankle OA, MSCs have been isolated from the synovial fluid 
of patients; however, MSC presence in talocrural subchondral bone, 
from which reparative cells released by microfracture would come 
from, remains unexplored.18 No existing study compares resident 
subchondral bone MSC topography and differentiation capacity be-
tween talus and distal tibia in ankle OA patients. A clear understand-
ing of resident MSCs behaviour, and how tissue damage affects their 
function, from both biological and mechanical standpoints, is of 
major importance for the development of novel regenerative medi-
cine strategies to treat ankle OA or osteochondral lesions.19
This study utilizes osteochondral talocrural specimens excised 
during ankle fusion to investigate the relative abundance and differ-
entiation capacity of MSCs in talar and distal tibia subchondral bone. 
It also aims to analyse MSC tissue topography in relation to cartilage 
damage and bone sclerosis in these specimens. We show that MSCs 
with an osteochondral-reparative phenotype are present in ankle 
OA joint and, notably localize near the OA joint surface, however, 
are highly correlated with regions of bone sclerosis, as such may be 
key drivers. These findings will help to inform future developments 
of enhanced regenerative therapies, such as microfracture, to enable 
an optimal release of MSC from the talar bone.
2  | METHODS
2.1 | Patient samples
Ethical approval for human ankle tissue collection (07/Q1205/27) 
and control Iliac crest (IC) tissue collection (06/Q1296/127) was 
obtained from NREC Yorkshire and Humberside National Research 
Ethics Committee, in compliance with the Helsinki Declaration of 
ethical principles for medical research involving human subjects. For 
these experiments, seven ankle OA patients (median age 66 years, 
range 34-73, 4 male 3 female) were included after signed consent 
was received, whether or not OA was post-traumatic was not known. 
Each patient underwent fusion of the talocrural joint for OA and was 
ambulatory prior to surgery. IC bone from 3 donors was obtained 
from patients undergoing orthopaedic surgery for metal removal 
following previous fracture, who were otherwise healthy (ages 32, 
38 and 42, 2 male, 1 female). Samples were placed immediately into 
saline after surgery and transferred to the laboratory. Non-diseased 
human cadaveric ankles (age 40-60 years, all-male, no evidence of 
ankle OA) were obtained from Medcure, USA, under local univer-
sity ethics, and stored at −80°C before distal tibia and talus were 
removed for imaging. Freezing meant that cadaveric samples were 
unsuitable for subsequent cell analysis.
2.2 | Microcomputed tomography (mCT) and 
image analysis
Three pairs of ankle OA talar and distal tibial osteochondral samples 
(approximately 35 mm × 25 mm × 9 mm and 28 mm × 2 mm × 7.8 mm 
from tibia and talus respectively) were retrieved and stored at 
−80°C. Following being defrosted and submerged in PBA, samples 
were imaged using mCT in a SkyScan 1278 (Bruker), at an 18-μm 
isotropic resolution. The cadaveric, non-diseased ankle bones were 
scanned at a 16-μm isotropic resolution using a micro-CT 100 
(ScanCo Medical). Anatomic areas were matched between the talus 
and tibia, selecting regions of loading. Bone volume of total volume 
(BV/TV) and subchondral bone plate (SBP) thickness were measured 
according to standard protocols. Briefly, BV/TV was measured using 
the BoneJ plug-in for NIH ImageJ (US National Institutes of Health), 
up to 3 mm depth from the SBP.20-22 SBP thickness was measured 
by reorientating the image to a transverse view and measuring the 
perpendicular distance from the beginning of bone to the first visible 
trabecular gap. Measurements were taken at twenty points for each 
bone and averaged.
2.3 | Histology and immunohistochemistry
Talus and distal tibial sections from 4 ankle OA patients were 
fixed in 3.7% formaldehyde (Sigma) for 1 week and subsequently 
decalcified in 0.5 mol/L EDTA (Fisher Scientific Ltd) for at least 
3 months, using dental X-ray (CS2200, Carestream Dental) to 
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confirm decalcification. Once decalcified, samples were fixed for 
a further 48 hours in 3.7% formaldehyde and then embedded in 
paraffin blocks.
Safranin O staining was performed on 5-µm sections of whole 
tibias and proximal tali according to standard protocols (all re-
agents from Sigma). Safranin O stained slides were scanned at 
10× using the Leica Aperio T2 (Leica Biosystems), and images 
were taken using Aperio Imagescope v12.4.0 (Leica Biosystems). 
Cartilage damage across the whole sagittal plane of both the talus 
and distal tibia was assessed by two independent observers using 
the OARSI OA cartilage histopathology system.23 Talus and tibial 
sections were additionally analysed using ImageJ v1.52a.20 Firstly, 
the SBP thickness was measured as previously described.24,25 
Briefly, the distance from the tidemark of calcified cartilage to 
the subchondral bone space was measured. The ratio of bone area 
to total area (BA/TA), starting beneath the SBP, was calculated 
across the whole joint by splitting the joint into series of tiles, up 
until 3 mm bone depth.
Immunohistochemistry for CD271-positive cells, a broadly 
used marker of in vivo bone-resident MSCs,26,27 was performed 
with monoclonal mouse anti-human antibody (clone ME20.4; 
Invitrogen) at 1:200 dilution followed by incubation with the 
EnVision + Dual Link System-HRP including horseradish peroxi-
dase and 3,3′-diaminobenzidine tetrahydrochloride (DAB) (Dako, 
Agilent) as previously described.28 Images were taken on a Nikon 
Eclipse Ti2-E camera (Nikon) and analysed using the Nuance 
Multispectral Imaging System (Caliper Lifesciences) for the bone 
area and CD271-positive area.29
2.4 | MSC isolation and culture
Talus and distal tibia samples of 3 ankle OA patients were sub-
merged in phosphate buffered saline ((PBS) Thermofisher), and ar-
ticular cartilage and soft tissue were removed using a scalpel and 
subsequently discarded. Remaining subchondral bone was minced 
mechanically into small fragments using a rongeur and then weighed. 
Samples were digested for 4 hours at 37°C in 3000 units of colla-
genase (Worthington Biochem) per gram of bone, with agitation 
every 30 minutes. The liquid fraction was filtered through a 44-µm 
pore filter (Corning). The filtrate was then passed through a 22-µm 
pore filter before centrifugation at 300 g for 10 minutes to pellet 
extracted cells.30 Cells were counted using haemocytometer and 
used for CFU-F assay or culture expansion. For culture expansion, 
106 cells were plated per 25-cm2 flask (Corning) in StemMACS™ 
MSC Expansion Media (Miltenyi Biotec) supplemented with 1% 
penicillin/streptomycin (P/S, Thermofisher). Media was changed 
twice per week. Cells were split at 80% confluency using trypsin 
(Thermofisher). Subsequent passages were plated at 105 MSCs per 
flask. MSCs were grown to either passage 2 for surface marker ex-
pression measurement by flow cytometry, or passage 3 for trilineage 
differentiation. The IC MSCs were isolated and expanded with the 
same method except that the removal of cartilage and soft tissue 
was not necessary. Non-diseased human ankles could not have cells 
extracted as freezing of tissue made them unsuitable for down-
stream analyses.
2.5 | CFU-F assay
MSCs were enumerated by CFU-F assay; freshly isolated cells 
were seeded at densities 2.5 × 103, 5 × 103 and 1 × 104 per dish in 
600-mm culture dishes (Corning) in duplicate with StemMACS ex-
pansion media supplemented with P/S. Media was changed twice 
a week. Dishes were fixed 3.7% in formaldehyde at 14 days and 
stained with methylene blue to visualize colonies as previously de-
scribed.31 Colony numbers were counted, averaged, and converted 
into CFU-F/106 cells and used to compare between talus, tibia and 
IC. Colony area and integrated density were measured using ImageJ. 
Briefly, colonies were converted to greyscale, and colony number 
and density were measured by the ‘analyse particles’ function in the 
program.32
2.6 | Flow cytometry
Surface expression of culture-expanded MSCs was assessed using 
the ISCT criteria of cultured MSCs.33 Briefly, after trypsinization, 
cells were pelleted by centrifugation at 500 g for 10 minutes, stained 
with relevant antibodies (all from Miltenyi Biotec) in the dark at 4°C 
for 15 minutes (positive markers: CD73-PE (Clone AD2,), CD90-
PerCP-Vio700 (Clone REA897), CD105-FITC (Clone 43A4E1); nega-
tive markers (all VioGreen): CD14 (Clone REA599), CD19 (Clone 
LT19) CD34 (Clone AC136), CD45 (Clone REA747), HLA-DR (Clone 
REA805)). Data acquisition was conducted using the Attune 2 Laser 
System (Invitrogen) and analysed using the Attune Cytometric 
Software (v2.1.0). Gates were applied to discount debris and then to 
measure the percentage of cells expressing these surface markers.
2.7 | Trilineage differentiation
MSCs were induced into chondrogenic, adipogenic and osteogenic 
cell lineages using specific differentiation media (Miltenyi Biotec).30 
Chondrogenesis was performed with 2.5 × 105 MSCs seeded in 
quadruplicate 1.5-mL Eppendorf tubes with 0.5 mL ChondroDIFF. 
For adipogenic differentiation, cells were cultured in triplicates in 
1 mL AdipoDIFF for 21 days, at a density of 4 × 104 per well in a 48-
well plate for Nile red/DAPI staining and 5 × 104 per well in a 24-well 
plate for oil red staining. Osteogenic differentiation was performed 
in triplicates with 1 × 104 cultured MSCs per well in a 12-well plate 
in 2 mL OsteoDIFF and cultured for 14 days for alkaline phosphatase 
and 21 days for Alizarin Red, calcium deposition and DNA measure-
ments. Glycosaminoglycan (GAG) production was used to quantify 
chondrogenesis as previously described.28 Adipogenesis was quanti-
fied by measuring oil red-positive area of the total area using ImageJ 
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F I G U R E  1   Morphological changes of OA visible by microcomputed tomography on proximal talus and distal tibia (n = 3 OA patients 
compared with n = 3 non-diseased controls, NDC). A, Talocrural tissues rendered in 3D. Healthy control images approximate analysed 
regions. A—anterior, P—posterior, M—medial, L—lateral. The OA talus and tibia are far smaller due to the minimal amount of bone removed 
from surgery. B, Change in subchondral bone plate (SBP) thickness in OA (symbols represent an average 20 measurements per donor). C, 
Change in bone volume of total volume (BV/TV) in the analysed regions in OA talus/tibia (symbols represent individual donors). D, Change in 
BV/TV by depth in non-diseased control talus/tibia. E, Change in BV/TV by depth from the SBP in talus. OA talus samples are measured to 
4 mm depth due to thinner samples being removed during surgery. F, Change in BV/TV by depth from SBP in tibia. Symbols and error bars on 
B/C show medians ± interquartile ranges (IQR) for 3 donors with a minimum of 200 slices. D-F show medians ± interquartile ranges (IQR) for 
3 donors with 100 slices per depth interval ***P < .001, using Wilcoxon signed-rank test
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v1.52a. Osteogenesis was quantified using calcium deposition nor-
malized to DNA content.34
2.8 | Statistical methods
Statistics were performed with GraphPad Prism v7.04 (GraphPad). 
Wilcoxon signed-rank test was used for mCT data, and Kruskal-
Wallis test with Dunn's post hoc test for multiple comparisons was 
used for all other tests. Significance was set at P < .05 (*P < .05, 
**P < .01, ***P < .001). The details of individual tests are presented 
in the respective figure legends.
3  | RESULTS
3.1 | Subchondral bone changes in the talus and 
distal tibia of ankle OA patients
To investigate specific subchondral bone behavioural changes in OA-
affected bones of the ankle, mCT was performed and compared with 
healthy control cadaveric samples from approximately same anatomic 
regions (Figure 1, red regions for controls). As seen, OA samples were 
smaller than control samples, due to tissue removed being minimized 
during surgery. The maximal depth of talus in particular was 3mm 
below the SBP. SBP thickness was measured as the distance to the 
first trabecular space (demonstrated in orange on Figure 1A).
Quantification of bone changes (Figure 1B) revealed an appar-
ent SBP thickness increase in OA compared with healthy in both 
talus and distal tibia, consistent with prior research in the ankle.35 
Interestingly, the overall volume as a fraction of total volume (BV/
TV) was unchanged between health and OA, measured to 3 mm 
depth from the SBP (Figure 1C). The talus appeared to have higher 
BV/TV than tibia in both OA and health, consistent with prior work.8 
To investigate whether BV/TV in OA changed by depth from the joint 
surface, samples were segmented in millimetre depths, and BV/TV 
measured for each 1 mm. In health, the tibia and talus measurements 
showed a similar gradual decrease in BV/TV as the depth increased, 
with the tibia being significantly thinner than the talus at each depth 
(P = .001; Figure 1D). In OA, where the talus could be only mea-
sured up to 3 mm depth from the SBP, it showed much greater BV/
TV increases near the SBP than in the tibia (Figure 1E), but also a 
depth-dependent loss in BV/TV which fell below that of the healthy 
talus at 2 mm. The tibia showed a similar trend (Figure 1F), while not 
as severe as the talus, but more so than the healthy control. These 
microstructural changes in OA talus and distal tibia indicated the 
predominant bone formation near the joint surface by the SBP thick-
ening and up to 2 mm beneath it.
3.2 | MSC frequency and colony characteristics in 
OA distal tibia and talar bone
To investigate the presence and functionality of MSCs in OA talus 
and distal tibia, following collagenase extraction of all cells from 
bone, standard MSC enumeration and differentiation assays (do-
nors ages 34, 58 and 66, 2 female and 1 male) were performed 
compared with control IC bone (donor ages 32, 38 and 4, 1 female 
and 2 male).36 Talus and distal tibia MSCs were found at a signifi-
cant, 30-fold higher frequency that in IC as a proportion of total 
cells ((Figure 2A), P = .0005, 0.0003, respectively). MSC colony-
forming behaviour was analysed by looking at the integrated density 
(Figure 2B) and colony area (Figure 2C). There were no apparent dif-
ferences between talus, tibia or IC colonies reflecting similar in vitro 
MSC proliferative potential.
3.3 | Differentiation capacity of MSCs from the OA 
talus and distal tibia
To confirm these colony-forming cells were MSCs, plastic-adher-
ent cells were expanded in standard MSC conditions and their 
F I G U R E  2   Properties of MSCs isolated from OA talus and tibia (n = 3 donors) and control Iliac crest (n = 3 donors) isolated by collagenase 
digestion of bone. A, Percentage of cells isolated which are MSCs, measured by CFU-F assay. Graphs show median ± interquartile range for 
3 repeated experiments from 3 donors. B, Integrated density of all MSC-initiated colonies from CFU-F assay measured using ImageJ. C, Area 
of all MSC-initiated colonies from CFU-F assay measured by ImageJ. Symbols on B and C represent individual colonies; lines and error bars 
represent medians and IQR. ***P < .001, Kruskal-Wallis test with Dunn's correction for multiple comparisons
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surface phenotype and differentiation capacity were measured 
using flow cytometry and standard trilineage differentiation assays, 
respectively.
Passage-2 adherent cells from distal tibia, talus and control IC 
cells were 95% or more positive for CD73, CD90 and CD105 and 
less than 3% positive for CD14, CD19, CD34, CD45 and HLA-DR 
(Figure 3A), consistent with MSC nature. All cultures successfully 
differentiated into bone, cartilage and fat lineages (Figure 3B-F). 
GAG content in day-21 chondrogenically differentiated pellets was 
similar between the OA talus and tibia; however, for each individual 
donor there was slightly higher GAG synthesis in the talus than tibia 
(Figure 3B). Both tibia and talus MSCs showed higher GAG concen-
tration than the IC MSCs, although this difference was only signifi-
cant for the talus (P = .012).
Adipogenic assays revealed that the talar cultures mostly 
showed the formation of ‘horseshoe’ fat-laden structures, con-
sisting of very small fat globules, suggesting slowed or halted dif-
ferentiation (Figure 3C). Oil red staining area was significantly 
fivefold lower in talar cultures compared with OA tibia or control 
IC when normalized to total cell area (P = .024, .0005, respectively 
(Figure 3D)). Alkaline phosphatase activity at day 14 and Alizarin 
Red staining at day 21 were evident, suggesting mineralization and 
deposition of calcium (Figure 3E). OA talar MSCs trended noticeably 
higher calcium production compared with tibia MSCs, and particu-
larly IC MSCs. However, this failed to reach statistical significance 
(Figure 3F). These results demonstrated that OA talus and tibial 
MSCs were tripotential, and capable of cartilage differentiation 
in vitro. Interestingly, the low level of OA talar MSC adipogenesis 
would suggest cells are primed for osteochondrogenesis.
3.4 | Histological cartilage and bone changes in 
ankle OA
To investigate whether any chondral regeneration from these MSCs 
takes place in ankle OA, Safranin O staining of OA distal tibia and talus 
samples was performed and cartilage damage was assessed using 
standard OARSI scoring system.37 All samples presented character-
istic OA osteochondral tissue morphology, although damage varied 
across the joint surface and between patients (Figure 4Ai representing 
early damage, ii representing severe damage). Less damaged areas pre-
sented GAG depletion (iii), progressing to minor (iv) and major cartilage 
fibrillation (v) whereas highly damaged regions presented complete 
cartilage denudation (vi) and extreme bone sclerosis (vii) (Figure 4A). 
Rarer abnormalities included subchondral bone cysts (viii) and osse-
ous repair over the previous surface (ix). No significant differences in 
F I G U R E  3   Characterization of 
culture-expanded MSCs from OA distal 
tibia and talus (n = 3 donors) and control 
Iliac crest bone (n = 3 donors). A, Surface 
phenotype of isolated cells from talus, 
tibia and IC after culture to passage 2 by 
flow cytometry. Negative markers reflect 
absence of haemopoietic lineage cells. 
Bar graphs represent means and standard 
deviations (SDs). B, Glycosaminoglycan 
concentration of cartilage pellets 
following chondrogenic C/D adipogenic 
assays: C, Oil red and Nile red staining of 
adipocyte differentiated MSCs. D, Oil red-
positive area of total area. E/F Osteogenic 
assays: E, Alkaline phosphatase and 
Alizarin Red staining to prove osteogenic 
differentiation of MSCs. F, Calcium 
deposition of differentiated cells 
normalized to DNA content. Box plots 
represent medians and IQR for 3 repeated 
experiments from 3 donors. *P < .05, 
Kruskal-Wallis test with Dunn's correction 
for multiple comparisons
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F I G U R E  4   Ankle tissues morphology and cell topography in end-stage osteoarthritis A, Safranin O histology of talus or distal tibial 
osteochondral tissue sections obtained from ankle fusion patients. Red staining shows glycosaminoglycans, and blue shows bone. (i—
Examples of grade 3 distal tibia/talus. ii—Example of grade 5 distal tibia/talus. iii—Glycosaminoglycan loss in cartilage. iv—Fibrillation of 
cartilage. v—Fibrillation and tidemark duplication. vi—Denuded cartilage. vii—Chondrocyte clustering. viii—A subchondral bone cyst. ix—
example of grade 6 tissue with osseous repair extending above the previous surface. x—and hypertrophy/clustering of chondrocytes (i scale 
bar 500 µm, ii-ix scale bar of 200 µm). B, Comparisons in OARSI cartilage damage score between the tibia and talus. Symbols represent 
individual patients. C, Change in subchondral bone plate thickness (SBP) with cartilage damage grade. D, Bone area of total area beneath the 
subchondral bone plate (SBP) between the talus and tibia, compared with the OARSI grade of the overlying cartilage. E, Bone area of total 
area (BA/TA) comparing different bone regions with the distance from the SBP. F, Comparison of changes in BA/TA of talar bone in grade 
3 vs grade 5 damaged regions near the subchondral bone plate vs further away. G, Comparison of changes in BA/TA of tibial bone in grade 
3 vs grade 5 damaged regions near the subchondral bone plate vs further away. C-G, Box plots represent medians and IQR from 3 donors 
measured from a minimum of 4 individual tiles. *P < .05, **P < .01, ***P < .001, Kruskal-Wallis test with Dunn's correction for multiple 
comparisons
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overall cartilage stage by OARSI score were found (Figure 4B) and no 
cartilage repair, seen as Safranin-positive tissue spanning the lesion 
margins and in the vicinity of chondrocyte clustering,38 was evident.
To investigate whether bone formation correlated with regions 
requiring chondral repair, the pattern of cartilage damage was in-
vestigated in relation to the subchondral bone changes. Indeed, 
SBP thickness increased significantly (threefold to sevenfold) with 
increasing cartilage damage in both talus and tibia, similar to that 
seen in mCT (Figure 4C). In tibia, there was a similar relationship be-
tween cartilage damage and subchondral bone density, measured as 
bone area as a fraction of total area (BA/TA), but not so in the talus 
(Figure 4D).
BA/TA as a function of distance from the SBP was next com-
pared between greatly damaged, grade 5 regions, to less damaged 
grade 3 regions. In both talus (Figure 4F) and tibia (Figure 4G), grade 
5 regions displayed higher BA/TA at both 0-1 and 1-3 mm depths 
measured; however, these trends were more dramatic and statisti-
cally significant in tibia (Figure 4G), suggesting that sclerotic reaction 
to cartilage loss in the tibia may be stronger than in the talus.
Combined with mCT work, these data indicated that bone for-
mation happens most near the joint surface, with increased SBP 
thickness and BV/TV closer to the joint surface. The bone response 
to cartilage loss may occur more rapidly in tibia than the talus, sug-
gesting different biomechanical pressures on resident cells including 
resident MSCs.
To confirm recent bone formation in talocrural tissue samples, we 
utilized picrosirius red staining, which has been previously used for 
revealing the collagen fibre organization and maturity in bone.39,40 
This dye stains immature collagen in new bone red under biphasic 
light, and old, mature bone collagen yellow/green. New collagen fi-
bres were seen aligned with the surface of the trabeculae, particu-
larly in grade 5 OA tissues (Figure S1A). Quantitative measurements 
of red area revealed more prominent new collagen formation in tibia 
than the talus (Figure S1B). In both talus and tibia, grade 5 regions 
had a trend for higher proportions of red staining compared with 
grade 3 regions (Figure S1C), indicating more new bone formation in 
these damaged regions. In addition, new bone formation in talocru-
ral tissues was evident by immunohistochemical staining for CD56 
(Figure S2A), a molecule present on bone-lining osteoblast progen-
itors, and E11, a marker of early embedding osteocytes, with both 
cell types present in the vicinity of cuboidal osteoblasts (Figure S2B). 
This illustrates the three progressive stages of the bone formation 
process in vivo.29,39
3.5 | Resident CD271+ MSC topography and 
relationship to bone changes in talus and distal tibia
To investigate whether subchondral bone MSCs could be responsible 
for forming new bone (and not cartilage) in ankle OA talus and distal 
F I G U R E  5   Relationships between 
CD271-positive cells and bone behaviour 
(A) High magnification images of 
immunohistochemistry for CD271, a 
native marker of MSCs, showing staining: 
(i) Overview of grade 3 and grade 5 
regions from talus and tibia. (ii/iii) High 
staining in SB areas beneath the tidemark. 
(iv) Areas of chondrocyte clustering. 
(v) bone marrow stroma around blood 
vessels. B, Comparison of total CD271 
coverage between talus and tibia. C, 
Relative CD271 coverage comparing 
regions near the subchondral bone plate 
to that further away. Box plots represent 
medians and IQR from 3 donors measured 
from a minimum of 4 individual tiles. D, 
The effect of overlying cartilage damage 
grade with CD271 coverage of trabecular 
space underneath. Symbols on B and 
D show individual measurements; lines 
and error bars represent medians and 
IQR. *P .05, **.01, Kruskal-Wallis test 
with Dunn's correction for multiple 
comparisons
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tibia, immunohistochemistry for CD271+ cells was next performed. 
In the areas with minimal cartilage damage (grade 3), CD271+ stain-
ing was found on the cells lining trabeculae, as expected (i, top pan-
els).25 Comparing less and more damaged regions (Figure 5Ai top 
vs bottom panels), CD271+ staining increased in worse-damaged 
(grade 5) regions, where positive staining increased particularly near 
the tidemark, within small cavities of the thickened SBP and lining 
trabecular spaces (Figure 5Aii-iii). Interestingly, CD271+ staining was 
identified next to proliferating chondrocytes in deep cartilage areas 
(iv), as well as prominent in marrow spaces with stromal fibrosis (v).
To quantify MSC abundance, whole sample mosaics up to 3 mm 
depth were created using stitched tiles, with each tile individually anal-
ysed for CD271+ area as a fraction of trabecular space area. In general, 
the talus and tibia showed similar abundance of CD271+ staining, if 
slightly higher in the talus (8.3% in talus vs 5.6% in tibia (Figure 5B)). 
Subsequent comparisons of CD271 coverage with depth showed that 
CD271+ cells were most frequent near the SBP, with ~10% coverage 
in the first millimetre, falling significantly to 4% (P = .0031) and 6% 
(0.0028) in the talus and tibia, respectively, at 1-3 mm depth compared 
with 0-1 mm depth (Figure 5C). There was a clear association between 
the grade of cartilage damage and the amount of CD271 staining 
within trabecular spaces, with significant differences in the tibia be-
tween grade 3 and 6 (P = .008), and 4 and 6 (P = .0197) (Figure 5D). 
This association is consistent with MSC behaviour primed for bone 
synthesis in the areas of cartilage damage and consequently, regions 
with abnormal biomechanics, particularly in the tibia.
4  | DISCUSSION
Many treatments of ankle OA, as well as osteochondral lesions of 
the talus, rely upon endogenous cells for repair, including microfrac-
ture and joint distraction, among others.41 However, the quality and 
quantity of endogenous repair cells facilitating these treatments, in-
cluding MSCs themselves, remain under-investigated.
In the present study, we show for the first-time subchondral 
bone MSC presence in both OA talus and tibia, with both talar and 
tibial MSCs showing enhanced chondrogenesis and osteogenesis 
than control IC MSCs, and reduced adipogenesis in talar MSCs. 
MSCs identified by the CD271 marker concentrated in regions of 
cartilage damage and new bone formation, illustrating an aberrant 
repair attempt, as seen in other human joints or animal models of 
OA.25,28,42 This indicates that multipotential cells are present in OA, 
with potential to augment repair enhancing cell homing, chondro-
genesis for cartilage repair and inhibiting osteogenesis, rather than 
injecting exogenous MSCs. By analysing both healthy and OA ankle 
tissues using 3D and 2D methods, the present study confirmed that 
bone changes in the ankle were similar to that in the inverted knee, 
with thickening of the SBP, and increased density of bone near the 
joint surface, with the talus matching changes to the femur, and dis-
tal tibia to the proximal tibia.43
Analysis of the mCT data for non-diseased specimens revealed 
that the SBP was thicker in tibia than the talus, and surprisingly, the 
overall BV/TV trend was the opposite, with a higher talar BV/TV in 
non-diseased state than tibia. Depth-dependent BV/TV correlated 
inversely with distance from the SBP, with the highest BV/TV at the 
joint surface. Previous work has shown that cartilage in the talus 
and distal tibia has similar thickness and mechanical properties.44,45 
Therefore, the main reason for this trend would appear to be the 
loading profile, with the convex talus directing force into the centre 
of the arch, whereas the concave tibia will have force over the whole 
SBP. In the knee, the convex femur has a thinner SBP, and the con-
cave tibial plateau has a thicker SBP, showing the same trend.46 As 
the shape of the bones converges force at the SBP or the centre of 
the arch, underlying bone mitigates less force, explaining this trend 
and emphasizing the role of biomechanical forces in normal bone 
structure of the ankle bones.
Comparing non-diseased to OA tissue, the SBP of the OA-
affected talus was thicker than the tibia, opposite than in non-dis-
eased specimens. SBP thickening is demonstrated in OA of both 
ankle and other joints, so the fact that the talus thickens more so 
than tibia is more likely to be due to local biomechanical differ-
ences, which may determine functional responses from endoge-
nous cells including MSCs.24,47 Overall BV/TV did not change in OA, 
but depth-dependent analysis revealed higher BV/TV in the first 
1 mm than healthy, and lower BV/TV after 2 mm, more drastically 
in the talus than the tibia. Previous research shows BV/TV changes 
are both joint and depth specific. The hip demonstrates increases 
in overall BV/TV in OA, but like the present study the knee does 
not.43,47 Segmentation by depth showed BV/TV in the OA knee is 
always higher than non-diseased tissue, suggesting different biome-
chanical OA-mediated changes between knee and ankle.43,48,49 As 
explained earlier, this is likely due to the loading profile of the two 
talocrural bones relative to other joints.50 Additionally, the talocrural 
joint is extremely congruent relative to other bones, which may also 
explain the differences to the knee.50 The present data demonstrate 
that OA structural changes occur mostly at the joint surface. SBP 
thickness increased more so in the talus, conversely BV/TV changes 
were greater in the tibia, suggesting different biomechanical adap-
tation to resist OA. It is possible that cartilage loss results in higher 
forces for the bone to mitigate, and so bone is synthesized at the 
naturally thinner SBP of the talus, whereas in the tibia as the plate 
is already thick, the relatively thinner bone just below will thicken.
Next, subchondral bone MSC presence and topography in rela-
tion to osteochondral changes in both distal tibia and talus was in-
vestigated. Li et al51 showed MSC presence in the calcaneus, another 
bone of the ankle, although by bone marrow aspiration, compared 
with this study isolating a higher proportion of MSCs by using colla-
genase bone digest. Isolated OA talar and tibial cells presented typ-
ical MSC surface phenotype, trilineage differentiation capacity and 
plastic adherence, the main criteria forth set by the ISCT.33 Similar 
to OA hip or knee, the relative frequency of OA MSCs was much 
higher than found in the IC.25,28 Both distal tibial and talar MSCs 
showed higher GAG synthesis than iliac crest, showing a higher 
affinity for cartilage synthesis. Differentiated talar MSCs trended 
higher calcium deposition and significantly lower adipogenesis than 
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the IC, whereas tibia did not. Lower talar MSC adipogenesis than 
tibia may be due to the talus having a higher BV/TV, meaning less 
trabecular cavity space and less need for fat as a space filler and 
load distributor.8 The present study demonstrates that endogenous 
MSCs of both the talus and tibia have the capacity for repair. The re-
duced inclination for adipogenesis may drive the improved outcome 
of microfracture in the ankle relative to other joints.52,53 However, 
other factors such as unique ankle biomechanics and donor age may 
play a role.44,45 As ankle OA patients are usually younger, this en-
hanced repair capability may have also been driven by these less 
aged MSCs, as MSCs are known to lose differentiation capability in 
older patients.54 As iliac crest and ankle tissues were not precisely 
age matched in the present study, the fact that talocrural chondro-
genic and osteogenic MSC differentiation appeared more potent 
than the relatively younger iliac crest MSCs furthers the argument 
that talocrural MSCs have a greater ability to initiate osteochondral 
joint repair. The higher GAG synthesis in both talar and tibial MSCs 
than iliac crest suggests a higher inclination for cartilage repair; how-
ever, it would be interesting in future to investigate the level of type 
I or type II collagen synthesis to assess whether synthesis favours 
fibrocartilage (predominantly type I collagen) or hyaline cartilage 
(type II), which may help to explain why microfracture only appears 
to work in the short term.55 This could be done by both transcript 
and protein levels.
The talus and tibia both had similar levels of typical OA dam-
age, and presented typical hallmarks as found in the hip or knee.37 
OARSI scores between both the talus and tibia were similar, al-
though slightly higher in the talus, akin to that of similar research.56 
Curiously, BA/TA was significantly correlated with OARSI grade in 
tibia, but not in talus. As the talus had twofold higher BA/TA in grade 
3 tissue than tibia (Figure 4D), this may mean the talus resists in-
creases due to a bone density limit. In previous research of the OA 
knee, the highest medial condyle BA/TA was 60% higher than the 
OA lateral condyle, similar to the upper range of the talus in this 
study.25 As shown by mCT in the present study, SBP thickness was 
higher in OA tissue than non-diseased, and BA/TA increased most 
in the first millimetre from the SBP. The SBP appears to compensate 
for cartilage destruction, focusing forces at the joint surface. Micro-
cracks in the SBP due to OA may also be enabling factors in synovial 
fluid and cartilage to reach bone. This crosstalk may be compound-
ing thickening of the bone further at superficial regions, on top of 
biomechanical stimuli.57,58
As a marker of bone-resident MSCs, CD271 has previously been 
used to look at changes in MSC localization in OA.26,27 In this study, 
talus showed slightly higher overall CD271 staining than tibia, poten-
tially correlating with the increased SBP thickening in talus. Similar 
to BV/TV changes, significantly more CD271+ MSCs were found 
within the first millimetre from the SBP compared with the next two 
millimetres in both bones. Additionally, CD271 area increased with 
OARSI damage grade particularly in the tibia consistent with greater 
BV/TV rise in response to cartilage damages in the tibia compared 
with talus. As such it appears, MSCs are involved in bone synthesis, 
with picrosirius red (Figure S1) showing where bone has thickened, 
that it is indeed new bone. Progressive bone formation in talocrural 
subchondral bone was also evident by co-localization of osteoblast 
progenitors, cuboid osteoblasts and early osteocytes to the same 
outer areas of trabeculae(Figure S2). As such, in vivo it appears 
MSCs may be key drivers of OA bone sclerosis, and correcting their 
behaviour may slow or prevent OA progression. Gene expression 
profiling of uncultured talocrural MSCs, as performed using knee 
MSCs from more and less damaged regions,25 would be necessary to 
confirm MSC redisposition to osteogenesis in OA talocrural tissues.
This study is limited by small numbers of ankle OA patients and 
the amount of tissue that could be removed during surgery, which 
aimed to minimize harm to the patient. Additionally, the choice of 
iliac crest as a control issue is a limitation, as this is not an articu-
lating joint region, with no need for cartilage synthesis and much 
less biomechanical stimuli. Although ideally non-diseased talocrural 
tissue would have been used, such samples are ethically complex, 
and the commercially available frozen cadaveric tissue was not suit-
able for functional MSC work. Iliac crest MSCs, as the best studied 
MSC type, are commonly used as a comparator in many previous 
studies and in our previous work, no gross differences in osteo- and 
chondrogenesis were observed between hip OA and IC MSC36,39 
suggesting that the present findings showing high osteo- and chon-
drogenesis in talocrural OA MSCs may be ankle joint-specific, com-
pared with IC. More consideration for age matching of talocrural 
and control tissues should be given in the future, considering MSC 
chondrogenesis in particular, declines with donor age.59 Due to the 
small amounts of tissue, particularly for the talus, we were unable to 
perform flow cytometry for the CD271 marker to quantify MSCs in 
talocrural tissues and compare their numbers with CFU-F numbers, 
or correlate with in situ staining data, as we performed in our other 
works.25,28,29,39 Future studies using sorted CD271+ MSCs from ta-
locrural bone followed by gene expression and functional analysis of 
the sorted cells would be needed to shed more light on potentially 
differential responses of talar and tibial MSCs to the OA process 
in the ankle, and guide towards more region-specific therapies for 
ankle OA.
To logically design treatments to reverse or slow down OA pro-
gression, first we need to understand disease progression, and why 
natural repair processes are failing. This study shows similar abun-
dance and in vitro potencies of MSCs in OA-affected talus and dis-
tal tibia. It highlights different biomechanical environments these 
MSCs are exposed to, both in health and in OA. Our data showing 
natural resistance of talar MSCs to adipogenesis provides potential 
explanation for the success of talar microfracture compared with 
other joints although other factors may be also at play.13,53 Our re-
sults show that in OA, CD271+ cells associate near the SBP, and 
accumulate with tissue damage. As these MSCs localize to the joint 
surface, it is possible that the current technique of drilling until 
there is a release of fat from the bone, is too deep, and could in-
form other treatments such as nanofracture, reducing the penetra-
tion depth but keeping the benefits of lessened tissue damage.60 
Focusing on new methods of MSC stimulation to form hyaline carti-
lage formation over bone synthesis is needed. This work also shows 
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that future work should focus on the modulation of biomechanical 
environments in different bones in the ankle joint. Some success in 
this area has been already achieved with ankle joint distraction.60-62 
Combining both biological and mechanical stimulation to direct 
MSC repair behaviour towards cartilage formation, and predicting 
how cells respond to a variety of biological and mechanical envi-
ronments, may lead to new joint-preserving treatments and avoid 
major surgical interventions.
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